Press Release Archive

10.22.2013

Pfizer Inc. Continues Development Program For Remoxy® (oxycodone) Extended-Release Capsules CII

10.18.2013

Pfizer Reports Top-Line Results From Two Lyrica® Capsules CV Phase 3b Studies

10.17.2013

Pfizer Receives European Approval For Label Update Regarding The Use Of Prevenar 13 In Certain High-Risk Populations

10.16.2013

Siemens enters into master agreement with Pfizer for companion diagnostics

10.16.2013

Grantmakers In Aging receives $1.3 million grant renewal from the Pfizer Foundation to help communities become more “age-friendly”

10.09.2013

MaRS Innovation and Pfizer Fund Bio-Manufacturing Technology

10.09.2013

ChapStick® Announces Olympic Gold Medalist Alex Morgan As New Face Of The Brand

10.09.2013

Pfizer Announces Top-Line Results Of The First Two Of Five Phase 3 Clinical Trials Of Tofacitinib In Adults With Moderate-To-Severe Chronic Plaque Psoriasis

10.03.2013

Pfizer Inc. Announces FDA Approval Of DUAVEETM (conjugated estrogens/ bazedoxifene) For The Treatment Of Moderate-To-Severe Vasomotor Symptoms (Hot Flashes) Associated With Menopause And The Prevention Of Postmenopausal Osteoporosis [1]

10.02.2013

International Atherosclerosis Society And Pfizer Independent Grants For Learning & Change Collaborate On New Grant Opportunity

10.01.2013

Pfizer Invites Public To View And Listen To Webcast Of October 29 Conference Call With Analysts

09.30.2013

Shantanu Narayen Elected To Pfizer’s Board Of Directors